PureTech Health【PRTC】銘柄情報

PureTech Health PLC (PRTC) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

17.42

( - )

買値

15.53

売値

19.80

出来高

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

前日終値

17.42

始値

時刻

最終取引時間

平均取引量 (3 か月)

財務取引量

VWAP

PureTech to Showcase Deupirfenidone Program at the American Thoracic Society International Conference

Presentations to highlight differentiated approach to advancing deupirfenidone, reinforcing its potential to serve as a new standard of care...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PureTech Announces Annual Results for Year Ended December 31, 2025

Refined strategy and disciplined execution position Company to unlock value from its portfolio, which includes Celea Therapeutics’ Phase 3-ready...

PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange

PureTech to maintain its primary listing on the London Stock Exchange Simplification of listing structure expected to enhance operational...

PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to...

PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML)

Phase 1b dataset with LYT-200 demonstrates complete responses and favorable tolerability across both R/R HR-MDS and R/R AML PureTech’s Founded...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

PRTC - Frequently Asked Questions (FAQ)

What is the current PureTech Health PLC share price?

The current share price of PureTech Health PLC is US$ 17.42

What is the 1 year trading range for PureTech Health PLC share price?

PureTech Health PLC has traded in the range of US$ 0.00 to US$ 0.00 during the past year

WooptdooU 6分前

The GREAT MAY DELAY #1 was on the industry, per the no risk of his own money ceo. If there is another delay, will they be selling more shares in advance of telling the risk taking shareholders?

LWLG

WooptdooU 8分前

The Mr "liked on linked-in" ceo needs to get on his throne and start liking. There MAY be a situation here.

LWLG

iHub News 9分前

Laser Photonics’ anti-drone system selected for U.S. defence evaluation programJune 4, 2026 2:45 AM
IH Market News

LASE

WooptdooU 12分前

Grifter insiders buy NO shares with their own money, no risk takers.

LWLG

Junivestor 20分前

Yeah, AVGO dropped 13% AH, guess that what pulled us down. Time to sign the agreement Yves! Let's go

LWLG

rakp 20分前

Yes, I hope so, must admit I am not too excited about Nathan's past, but we have to wait and see what he comes up with. He may bring in a totally different company run by others. I remember one of the previous partners wanted to start something new, but he told me the majority shareholder didn't wan

CCLX

12yearplan 22分前

12.29 both (4pm close). Naz has real time all day.. 11.71 in AH (8pm close)
https://www.nasdaq.com/market-activity/stocks/lwlg
https://ca.finance.yahoo.com/quote/LWLG/

LWLG

Wallstreeter$$$ 23分前

It looks more that way with each passing week and IMO it could be abt getting more viable data to submit. Don't seem to me it takes 2 months (double the original timeframe) to reformat a sub.

RDGL

Genz2 28分前

Elon, my father when he was alive worshipped the ground you walked on and he spoke about you and only had good things to say about you and his Tesla Model 3!!! I wonder what he would he would say about you becoming a trillionaire?? My father used to donate to a hunger organization as he once faste

TSLA

Wallstreeter$$$ 29分前

And so the SC🤡 show goes on. lol

RDGL

WALL STREET KID 35分前

$AMC SHORTS IN NEED SHARE! SHARE BUYBACKS

https://youtu.be/GDGA8Ha8B5E?si=-j7bq24Q7BgM0ZkF

AMC

Stock_Gambit 39分前

WOW... 5m .0001's were sold/bought today. Is this going to break the seal or a one time thing??

MDCE

LawDawg5 40分前

PROMISES BROKEN = SOCIALISM 😡

FNMA

MusicExec 42分前

Do you really believe in magic & financial wizardry ?
https://open.spotify.com/track/1udKn1oNKYQSQ9OmiIWCMu?si=qgO_5RzPRAuSYYMKcvTUbA

SONG

Investor2014 43分前

I have news for you - my use of (in fact very little) time here is entirely mine to decide.

Have skimmed your 24 posts on the Anavex message board, I would say that your bullish FDA/EMA chess thesis has been proven incorrect. Perhaps you can point to a post of your's that you feel has

AVXL

G-star 49分前

Wowzie, a lot of fancy buzzwords and big numbers, but very little hard evidence.

Comparing BIEL to companies like OpenAI, SpaceX, WULF, or CIFR doesn't make BIEL worth more. Talking about "AI," "venture capital," "5,000% gains," and "$1/share" sounds exciting, but it doesn't change th

BIEL

US Market News 54分前

Guardian Metal Resources PLC Announces Discovery of Tremor Zone at Pilot MountainJune 4, 2026 2:00 AM
ACCESS NewswireLONDON, UK / ACCESS Newswire / June 4, 2026 / Guardian Metal Resource

GMTL

US Market News 54分前

Solidion Technology Unveils Patented Extreme-Climate Battery Technology Targeting Low Earth Orbit-Based Artificial Intelligence Data Centers, Lunar Economy, and SpaceJune 4, 2026 2:00 AM
PR Newswire (US) Proprietary Gen-ECB Platform Engin

STI

Junivestor 58分前

I see some differences in AH price. Yahoo and nasdaq tell me 12.20 while other sites give me 11:60

LWLG

satter 1時間前

***Correction***

I believe 300 million from the 810 million is still legally locked to expire at a later date, belonging to different insiders.

Wrong. My bad. The actual ledger entries from December 11, 2025, show the diluti

HIRU

dinogreeves 1時間前

Good job.

BTCUSD

ducci1 1時間前

ES--Support Retrace ---61% 7527 ?

SPY

ducci1 1時間前

SPX Support--Retrace---78% 7569---61% 7518---50% 7482 !----Macro--SPX Daily CCI --3 Lower Low Divergence--Mkt Down---Rule of 3!

SPY

pinkslipjunkie 1時間前

He still might find his way back home...

halldorson 1時間前

I am still holding for my July 10th submission date -

RDGL

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

PureTech Health PLC (PRTC)

PureTech Health PLC (PRTC) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

PRTC 最新ニュース

PureTech to Showcase Deupirfenidone Program at the American Thoracic Society International Conference

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PureTech Announces Annual Results for Year Ended December 31, 2025

PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange

PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors

PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML)

PureTech to Showcase Deupirfenidone Program at the American Thoracic Society International Conference

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PureTech Announces Annual Results for Year Ended December 31, 2025

PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange

PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors

PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML)

PureTech Health: Notice of Results

PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine

PRTC - Frequently Asked Questions (FAQ)

PRTC 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR